How I’d invest £75 a week to earn a passive income

Rupert Hargreaves explains the approach he would use to generate a passive income from a weekly investment of £75 in the stock market.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Thin line graph

Image source: Getty Images

I am looking to invest a lump sum of £75 a week to build a passive income stream for life. This might appear to be a small sum of money, but it could grow to become a substantial nest egg in the long term. 

Investing for a passive income

The strategy I plan to use to invest for income is relatively simple. I am looking to buy high-quality income and growth stocks and hold them for the long run. 

Using this approach, I will benefit from both capital growth and income growth. Overall, this should enable me to generate higher returns than I may otherwise be able to using a simple strategy based on buying income stocks. 

Of course, there is no guarantee I will be able to build a passive income nest egg. Neither is there any guarantee that the income stocks I choose will continue to produce dividend income indefinitely.

As dividends are paid from company profits, if earnings fall, the corporations may have to cut their payments to investors. This could leave a big hole in my income strategy. 

One approach I will be using to try and overcome this issue is diversification. By building a highly diversified portfolio of income and growth stocks, I believe I can reduce the risk that one dividend cut will have a significant impact on the overall performance of my nest egg. 

Income and growth

Hikma and AstraZeneca are examples of companies I will be looking to buy. These pharmaceutical firms offer dividend yields of between 1% and 2%. More importantly, they have a long track record of dividend growth.

They are also both investing heavily in their futures and this should translate into earnings growth, allowing the companies to increase their dividends to investors. Earnings growth may also translate into capital gains. This will provide a double tailwind of both income and capital growth in my portfolio. 

As a rough guide to the sort of profits I could earn using this strategy, I have estimated an annual growth rate of 10% on my money. At this rate, a weekly investment of £75, or £325 a month, could grow to be worth £66,000 within a decade.

If I then switched from income and growth to just income, I estimate I could earn an annual passive income of £5,300 on my money. This assumes I can acquire dividend stocks with a yield of 8%. Looking at what is available on the market right now, I believe this is possible, although it is not guaranteed. 

This is the strategy I would use to invest £75 a week and earn a passive income. It is not a waterproof strategy, but as the example outlined above shows, it could be possible to build a passive income of £5,300 per annum using this method.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Down 32% and with a P/E of 9.5, is this FTSE 250 share too cheap to ignore?

This FTSE 250 share is in freefall after slashing guidance for this financial year. But Royston Wild eyes a potential…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

Why high oil prices could be good news for Lloyds shares

Jon Smith talks through the implications of elevated oil prices and translates that through to the potential impact on Lloyds'…

Read more »

Investing Articles

Lists of income stocks to buy almost never include this one — but with a forecast 8.2% yield, I think they should!

This FTSE firm, not always seen as an income play, has a forecast yield of 8.2%, underlining why it's one…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Aviva’s share price is down 13% to under £7, despite outstanding 2025 results! Time for me to buy more?

I think Aviva’s share price reflects an outdated view of the business, and that gap between perception and reality is…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

An 8.4% forecast yield but down 16%! Time for me to buy more of this FTSE 100 passive income star?

This FTSE 100 passive‑income machine is delivering rising payouts and strong forecasts, and its share price suggests the market hasn’t…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

£10,000 invested in Meta Platforms Stock 5 years ago is now worth…

Meta Platforms has been throwing good money after bad at Reality Labs since 2021, but the stock has more than…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£7,500 invested in Diageo shares 5 weeks ago is now worth…

Our writer wonders if Diageo shares are worth a look at a 14-year low, or whether this FTSE 100 spirits…

Read more »